Neuronetics (STIM) Research & Development (2017 - 2026)

Neuronetics (STIM) has 10 years of Research & Development data on file, last reported at $1.4 million in Q1 2026.

• Research & Development for Q1 2026 came in at $1.4 million, down 15.59% year-over-year; the trailing twelve-month figure through Mar 2026 was $6.3 million (down 47.4% YoY), and the FY2025 annual result was $6.6 million, down 48.45% from the prior year.
• Research & Development declined to $1.4 million in Q1 2026 per STIM's latest filing, from $1.7 million in the prior quarter.
• Over five years, Research & Development peaked at $5.8 million in Q4 2024 and troughed at $1.4 million in Q1 2026.
• A 5-year average of $2.3 million and a median of $2.2 million in 2023 frame the typical range for Research & Development.
• The sharpest annual moves came in 2024 and 2025: Research & Development surged 161.53% in 2024, then tumbled 71.14% in 2025.
• A 5-year view of Research & Development shows it stood at $3.1 million in 2022, then retreated by 29.69% to $2.2 million in 2023, then surged by 161.53% to $5.8 million in 2024, then plunged by 71.14% to $1.7 million in 2025, then slipped by 18.13% to $1.4 million in 2026.
• Business Quant data shows STIM's Research & Development at $1.4 million in Q1 2026, $1.7 million in Q4 2025, and $1.5 million in Q3 2025.